A detailed history of Sittner & Nelson, LLC transactions in Viatris Inc stock. As of the latest transaction made, Sittner & Nelson, LLC holds 43 shares of VTRS stock, worth $538. This represents 0.0% of its overall portfolio holdings.

Number of Shares
43
Previous 1,670 97.43%
Holding current value
$538
Previous $17,000 100.0%
% of portfolio
0.0%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$10.32 - $12.13 $16,790 - $19,735
-1,627 Reduced 97.43%
43 $0
Q2 2024

Aug 13, 2024

SELL
$10.05 - $12.02 $70 - $84
-7 Reduced 0.42%
1,670 $17,000
Q3 2023

Nov 13, 2023

SELL
$9.59 - $11.35 $2,685 - $3,178
-280 Reduced 14.31%
1,677 $16,000
Q2 2023

Aug 14, 2023

SELL
$9.02 - $10.29 $216 - $246
-24 Reduced 1.21%
1,957 $19,000
Q1 2023

May 09, 2023

BUY
$9.2 - $12.26 $12,843 - $17,114
1,396 Added 238.63%
1,981 $19,000
Q4 2022

Feb 01, 2023

SELL
$8.72 - $11.56 $78 - $104
-9 Reduced 1.52%
585 $6,000
Q3 2022

Nov 14, 2022

SELL
$8.48 - $11.13 $6,173 - $8,102
-728 Reduced 55.07%
594 $5,000
Q2 2022

Aug 12, 2022

BUY
$9.95 - $12.27 $69 - $85
7 Added 0.53%
1,322 $14,000
Q4 2021

Feb 09, 2022

BUY
$12.09 - $14.68 $5,682 - $6,899
470 Added 55.62%
1,315 $18,000
Q3 2021

Nov 12, 2021

SELL
$13.25 - $15.13 $18,086 - $20,652
-1,365 Reduced 61.76%
845 $11,000
Q2 2021

Aug 12, 2021

SELL
$12.97 - $16.15 $1,115 - $1,388
-86 Reduced 3.75%
2,210 $32,000
Q1 2021

May 06, 2021

SELL
$13.59 - $18.54 $6,523 - $8,899
-480 Reduced 17.29%
2,296 $32,000
Q4 2020

Feb 16, 2021

BUY
$14.3 - $18.74 $39,696 - $52,022
2,776 New
2,776 $52,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.2B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Sittner & Nelson, LLC Portfolio

Follow Sittner & Nelson, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sittner & Nelson, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sittner & Nelson, LLC with notifications on news.